Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 10. Отображено 7.
08-03-2012 дата публикации

Topical antiviral formulations

Номер: US20120058959A1
Автор: Darby C. Brown, Kristen A. Brown
Принадлежит: VIRAVERT LLC

The disclosure provides novel topical antiviral pharmaceutical compositions comprising one or more antiviral compounds and 2-deoxy-D-glucose in the form of lip-balms, creams and ointments. A specific embodiment discloses a lip-balm composition comprising acyclovir and 2-deoxy-D-glucose.

Подробнее
Номер записи: 1
13-06-2013 дата публикации

Topical antiviral formulations

Номер: US20130150312A1
Автор: Darby C. Brown, Kristen A. Brown
Принадлежит: 3B Pharmaceuticals Inc

The disclosure provides antiviral pharmaceutical compositions comprising one or more antiviral compounds and 2-deoxy-D-glucose in the form of lip-balms, creams and ointments. A specific embodiment discloses a lip-balm composition comprising acyclovir and 2-deoxy-D-glucose.

Подробнее
Номер записи: 2
26-01-2017 дата публикации

INTRANASAL NALTREXONE

Номер: US20170020862A1
Автор: Brown Darby C., Gertz Beau, Montgomery Jason
Принадлежит:

A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue. 1. A pharmaceutical composition consisting essentially of naltrexone hydrochloride and water , the composition capable of maintaining at least about 90% of said naltrexone hydrochloride in undegraded form after storage for 180 days at room temperature.2. The composition of claim 1 , wherein the composition is capable of maintaining at least about 95% of said naltrexone in undegraded form after storage for 180 days at room temperature.3. The composition of claim 1 , wherein the naltrexone hydrochloride is present in the composition in an amount between about 0.001 mg/mL and 20 mg/mL.4. The composition of claim 3 , wherein the naltrexone hydrochloride is present in the composition in an amount between 0.5 mg/mL and 5 mg/mL.5. The composition of claim 1 , wherein the composition consists of naltrexone hydrochloride and water.6. The composition of claim 1 , wherein the composition does not contain a preservative.7. The composition of wherein the composition does not contain a buffering agent.8. The composition of wherein the composition does not contain a tonicity agent.9. The composition of claim 1 , wherein the composition does not contain a pH adjusting agent.10. The composition of claim 1 , wherein the composition consists of naltrexone hydrochloride dissolved in water at a concentration in the range of from about 0.001 mg/mL to about 20 mg/mL in sterile water or water for injection.11. A method for treating a patient suffering from claim 1 , or suspected of suffering from claim 1 , an opioid agonist overdose claim 1 , the method comprisingadministering transmucosally to the patient a first dose of a pharmaceutical composition consisting essentially of a pharmaceutically effective dose of naltrexone hydrochloride and water; wherein ...

Подробнее
Номер записи: 3
19-06-2014 дата публикации

INTRANASAL NALTREXONE

Номер: US20140171458A1
Автор: Brown Darby C., Gertz Beau, Montgomery Jason
Принадлежит: 3B Pharmaceuticals, Inc.

A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue. 1. A pharmaceutical composition consisting essentially of naltrexone hydrochloride and water , the composition capable of maintaining at least about 90% of said naltrexone hydrochloride in undegraded form after storage for 180 days at room temperature.2. The composition of wherein the composition is capable of maintaining at least about 95% of said naltrexone in undegraded form after storage for 180 days at room temperature.3. The composition of wherein the naltrexone hydrochloride is present in the composition in an amount between about 0.001 mg/mL and 20 mg/mL.4. The composition of wherein the naltrexone hydrochloride is present in the composition in an amount between 0.5 mg/mL and 10 mg/mL.5. The composition of wherein the naltrexone hydrochloride is present in the composition in an amount between 1 mg/mL and 3 mg/mL.6. The composition of wherein the naltrexone hydrochloride is present in the composition in about 2 mg/mL.7. The composition of wherein the composition consists of naltrexone hydrochloride and water.8. The composition of wherein the composition does not contain a preservative.9. The composition of wherein the composition does not contain a buffering agent.10. The composition of wherein the composition does not contain a tonicity agent.11. The composition of wherein the composition does not contain a pH adjusting agent.12. The composition of wherein the composition consists of naltrexone hydrochloride dissolved in water at a concentration in the range of from about 0.001 mg/mL to about 20 mg/mL claim 1 , about 0.05 mg/mL to about 10 mg/mL claim 1 , about 0.5 mg/mL to about 5 mg/mL claim 1 , about 1 mg/mL to about 3 mg/mL claim 1 , or about 2 mg/mL in sterile water or water for injection.13. A method for treating a ...

Подробнее
Номер записи: 4
07-08-2014 дата публикации

Topical antiviral formulations

Номер: US20140221297A1
Автор: Darby C. Brown, Kristen A. Brown
Принадлежит: 3B Pharmaceuticals Inc

The disclosure provides antiviral pharmaceutical compositions comprising one or more antiviral compounds and 2-deoxy-D-glucose in the form of lip-balms, creams and ointments. A specific embodiment discloses a lip-balm composition comprising acyclovir and 2-deoxy-D-glucose.

Подробнее
Номер записи: 5
04-09-2014 дата публикации

Intranasal naltrexone

Номер: US20140249172A1
Автор: Beau Gertz, Darby C. Brown, Jason Montgomery
Принадлежит: 3B Pharmaceuticals Inc

A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue.

Подробнее
Номер записи: 6
01-10-2014 дата публикации

Antiviral formulations

Номер: EP2782585A1
Автор: Darby C. Brown, Kristen A. Brown
Принадлежит: 3B Pharmaceuticals Inc

The disclosure provides antiviral pharmaceutical compositions comprising one or more antiviral compounds and 2-deoxy-D-glucose. In embodiments, the disclosure provides compositions in the form of lip-balm, cream and ointments. A specific embodiment discloses a lip-balm composition comprising acyclovir and 2- deoxy-D-glucose.

Подробнее
Номер записи: 7